The Gila monster enters the scene A solution to the difficulties with GLP-1 eventually came from a totally unexpected source - the Gila monster (figure 32)
Meta-analyses indicate context-specific benefit rather than universal advantage, reinforcing the clinical importance of baseline biomarker evaluation before initiating supplementation strategies in otherwise healthy individuals
Severe reactions including anaphylaxis can occur in people who are allergic to ingredients in GLP-1 medications
After 6 months, statistically significant differences were seen in the following assessment instruments: visual analogue scale (VAS), SF-36, the Western Ontario and McMaster Universities Arthritis Index (WOMAC), and Lequesne Index
When side effects occur, many users report that symptoms are temporary and resolve after treatment adjustments or discontinuation
Patients with FBS 126 mg/dL, HbA1c 6.5%, and/or currently using antidiabetic medication were defined as having diabetes according to the criteria of the Japan Diabetes Society [14]